OBESITY AS A PERSISTENT RISK BEYOND ANEUPLOIDY
North American Proceedings in Gynecology and Obstetrics - Supplemental · 26.07.2026 · Suppl (MRSi)
DOI: 10.54053/001c.165491 ↗Kurz gefasst
Fachartikel in der Zeitschrift North American Proceedings in Gynecology and Obstetrics - Supplemental, online erschienen am 26.07.2026. Verfasst von Janelle Jackman und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Maternal obesity remains a prevalent metabolic factor that may independently impair reproductive success. Whether obesity compromises live birth and implantation rates, after controlling for euploidy embryo status, is important to determine.
Objective
To evaluate the impact of body mass index (BMI) on live birth rates (LBR) and clinical miscarriage rates (MC) from preimplantation genetic testing for aneuploidy (PGT-A) tested single frozen embryo transfer (eSET) cycles.
Design
Retrospective cohort study. Materials and Methods: A total 3,435 PGT-A tested eSET cycles (2023–2024) at a single private fertility center were stratified by body mass indexes underweight (
Zitieren
APA
Jackman, J., Daram, N., Sandefer, A., Poulos, K., Tsoutsias, D., & Beltsos, A. (2026). OBESITY AS A PERSISTENT RISK BEYOND ANEUPLOIDY. North American Proceedings in Gynecology and Obstetrics - Supplemental, Suppl(MRSi). https://doi.org/10.54053/001c.165491
Vancouver
Jackman J, Daram N, Sandefer A, Poulos K, Tsoutsias D, Beltsos A. OBESITY AS A PERSISTENT RISK BEYOND ANEUPLOIDY. North American Proceedings in Gynecology and Obstetrics - Supplemental. 2026;Suppl(MRSi). doi:10.54053/001c.165491
BibTeX
@article{Jackman2026,
author = {Jackman, Janelle and Daram, Naveena and Sandefer, Alyssa and Poulos, Katerina and Tsoutsias, Demi and Beltsos, Angeline},
title = {OBESITY AS A PERSISTENT RISK BEYOND ANEUPLOIDY},
journal = {North American Proceedings in Gynecology and Obstetrics - Supplemental},
year = {2026},
volume = {Suppl},
number = {MRSi},
doi = {10.54053/001c.165491}
}
EUVIMED